| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alternative Splicing | 70 | 2025 | 375 | 13.390 |
Why?
|
| Myotonic Dystrophy | 40 | 2025 | 150 | 12.740 |
Why?
|
| RNA-Binding Proteins | 55 | 2025 | 609 | 8.820 |
Why?
|
| Muscle, Skeletal | 27 | 2023 | 1052 | 4.080 |
Why?
|
| RNA Splicing | 22 | 2024 | 250 | 3.840 |
Why?
|
| RNA Precursors | 22 | 2016 | 65 | 3.480 |
Why?
|
| Exons | 32 | 2024 | 832 | 3.310 |
Why?
|
| RNA, Messenger | 33 | 2024 | 2902 | 3.280 |
Why?
|
| CELF1 Protein | 23 | 2020 | 50 | 2.670 |
Why?
|
| Myocardium | 14 | 2025 | 1046 | 2.340 |
Why?
|
| RNA | 13 | 2018 | 601 | 2.300 |
Why?
|
| Trinucleotide Repeat Expansion | 13 | 2024 | 127 | 1.960 |
Why?
|
| Heart | 12 | 2024 | 749 | 1.920 |
Why?
|
| Gene Expression Regulation, Developmental | 10 | 2018 | 1046 | 1.740 |
Why?
|
| Myotonin-Protein Kinase | 11 | 2025 | 45 | 1.720 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 2 | 2024 | 40 | 1.490 |
Why?
|
| RNA Stability | 6 | 2020 | 84 | 1.410 |
Why?
|
| Animals | 74 | 2025 | 36364 | 1.350 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2023 | 107 | 1.280 |
Why?
|
| Muscle Development | 5 | 2023 | 76 | 1.270 |
Why?
|
| MicroRNAs | 6 | 2020 | 951 | 1.240 |
Why?
|
| Mice | 41 | 2025 | 18884 | 1.210 |
Why?
|
| Gene Expression Regulation | 15 | 2017 | 2656 | 1.180 |
Why?
|
| Disease Models, Animal | 14 | 2025 | 4772 | 1.160 |
Why?
|
| Introns | 14 | 2019 | 313 | 1.080 |
Why?
|
| RNA, Long Noncoding | 2 | 2020 | 246 | 1.000 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 2020 | 75 | 0.930 |
Why?
|
| DNA-Binding Proteins | 10 | 2025 | 2161 | 0.930 |
Why?
|
| CRISPR-Cas Systems | 2 | 2017 | 292 | 0.910 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2024 | 38 | 0.910 |
Why?
|
| MEF2 Transcription Factors | 2 | 2014 | 41 | 0.880 |
Why?
|
| Cell Line | 17 | 2024 | 2837 | 0.870 |
Why?
|
| Myoblasts | 4 | 2024 | 36 | 0.860 |
Why?
|
| Base Sequence | 24 | 2018 | 3171 | 0.860 |
Why?
|
| Cell Nucleus | 12 | 2016 | 688 | 0.840 |
Why?
|
| Ribonucleoproteins | 5 | 2015 | 66 | 0.830 |
Why?
|
| Disease | 3 | 2012 | 134 | 0.820 |
Why?
|
| Troponin T | 14 | 2009 | 297 | 0.810 |
Why?
|
| Receptor, Insulin | 5 | 2013 | 70 | 0.800 |
Why?
|
| RNA Splicing Factors | 4 | 2018 | 55 | 0.800 |
Why?
|
| Physical Endurance | 2 | 2019 | 51 | 0.790 |
Why?
|
| Mice, Transgenic | 13 | 2025 | 2527 | 0.780 |
Why?
|
| Enhancer Elements, Genetic | 9 | 2005 | 315 | 0.740 |
Why?
|
| DNA Repeat Expansion | 3 | 2017 | 79 | 0.660 |
Why?
|
| Mutation | 14 | 2017 | 6289 | 0.660 |
Why?
|
| Microsatellite Repeats | 3 | 2020 | 240 | 0.650 |
Why?
|
| Troponin | 7 | 1998 | 78 | 0.650 |
Why?
|
| Muscular Atrophy | 1 | 2020 | 84 | 0.640 |
Why?
|
| Heart Conduction System | 2 | 2018 | 149 | 0.630 |
Why?
|
| Humans | 76 | 2025 | 133854 | 0.630 |
Why?
|
| Muscle Proteins | 3 | 2018 | 423 | 0.610 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 100 | 0.590 |
Why?
|
| Pregnancy, Animal | 1 | 2018 | 75 | 0.590 |
Why?
|
| Calpain | 1 | 2018 | 43 | 0.580 |
Why?
|
| CELF Proteins | 9 | 2015 | 14 | 0.580 |
Why?
|
| Protein Kinase C | 2 | 2009 | 151 | 0.580 |
Why?
|
| Proteostasis | 1 | 2018 | 37 | 0.570 |
Why?
|
| Muscle Weakness | 1 | 2018 | 95 | 0.560 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 73 | 0.560 |
Why?
|
| 3' Untranslated Regions | 5 | 2015 | 182 | 0.560 |
Why?
|
| Calcium | 3 | 2017 | 1146 | 0.560 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 48 | 0.550 |
Why?
|
| Fragile X Syndrome | 2 | 2016 | 155 | 0.550 |
Why?
|
| Calcineurin | 1 | 2017 | 101 | 0.540 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2017 | 453 | 0.530 |
Why?
|
| Molecular Sequence Data | 17 | 2012 | 3970 | 0.520 |
Why?
|
| Growth and Development | 1 | 2016 | 23 | 0.510 |
Why?
|
| Organogenesis | 2 | 2014 | 83 | 0.500 |
Why?
|
| Nuclear Proteins | 8 | 2015 | 1334 | 0.500 |
Why?
|
| Protein Isoforms | 6 | 2023 | 429 | 0.500 |
Why?
|
| Genetic Therapy | 4 | 2014 | 733 | 0.480 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2013 | 87 | 0.480 |
Why?
|
| Genes, Reporter | 2 | 2006 | 395 | 0.480 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2019 | 1326 | 0.460 |
Why?
|
| RNA Splice Sites | 4 | 2019 | 98 | 0.450 |
Why?
|
| Ataxia | 1 | 2016 | 177 | 0.450 |
Why?
|
| Gene Expression | 5 | 2019 | 1614 | 0.450 |
Why?
|
| Fibroblasts | 4 | 2014 | 922 | 0.450 |
Why?
|
| Chickens | 10 | 2009 | 640 | 0.440 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 56 | 0.440 |
Why?
|
| Muscular Diseases | 1 | 2015 | 117 | 0.430 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2013 | 8 | 0.430 |
Why?
|
| Pyruvate Kinase | 1 | 2013 | 11 | 0.420 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 190 | 0.420 |
Why?
|
| Glucose | 3 | 2018 | 924 | 0.420 |
Why?
|
| Trans-Activators | 3 | 2006 | 830 | 0.410 |
Why?
|
| Cell Differentiation | 5 | 2023 | 2026 | 0.410 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 121 | 0.410 |
Why?
|
| Energy Metabolism | 2 | 2018 | 809 | 0.390 |
Why?
|
| Ribonuclease H | 1 | 2012 | 5 | 0.390 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 3476 | 0.390 |
Why?
|
| Muscular Dystrophies | 2 | 2011 | 55 | 0.380 |
Why?
|
| Genes, Developmental | 1 | 2011 | 3 | 0.380 |
Why?
|
| Up-Regulation | 4 | 2023 | 905 | 0.370 |
Why?
|
| Mice, Knockout | 6 | 2023 | 3969 | 0.370 |
Why?
|
| Heart Diseases | 1 | 2016 | 522 | 0.370 |
Why?
|
| RNA, Untranslated | 2 | 2009 | 120 | 0.370 |
Why?
|
| Cytoplasm | 2 | 2020 | 302 | 0.360 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 397 | 0.360 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 2 | 2015 | 11 | 0.350 |
Why?
|
| Myocytes, Cardiac | 2 | 2014 | 672 | 0.350 |
Why?
|
| Animals, Newborn | 4 | 2017 | 1045 | 0.330 |
Why?
|
| Pentamidine | 1 | 2009 | 3 | 0.330 |
Why?
|
| DNA Primers | 7 | 2009 | 671 | 0.330 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2009 | 8 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 7 | 2015 | 1162 | 0.320 |
Why?
|
| Spliceosomes | 3 | 2015 | 57 | 0.320 |
Why?
|
| Alleles | 4 | 2018 | 1706 | 0.320 |
Why?
|
| Phenotype | 5 | 2025 | 4532 | 0.320 |
Why?
|
| Binding Sites | 7 | 2010 | 1371 | 0.310 |
Why?
|
| HeLa Cells | 8 | 2015 | 828 | 0.310 |
Why?
|
| RNA, Small Nuclear | 1 | 2009 | 50 | 0.310 |
Why?
|
| Green Fluorescent Proteins | 3 | 2007 | 401 | 0.310 |
Why?
|
| Regeneration | 1 | 2011 | 232 | 0.300 |
Why?
|
| Muscles | 4 | 2006 | 307 | 0.290 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2010 | 217 | 0.280 |
Why?
|
| Protein Kinase C-alpha | 1 | 2007 | 20 | 0.280 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2007 | 3 | 0.270 |
Why?
|
| Chloride Channels | 2 | 2009 | 62 | 0.270 |
Why?
|
| Cells, Cultured | 9 | 2012 | 3167 | 0.260 |
Why?
|
| Transfection | 8 | 2007 | 1089 | 0.260 |
Why?
|
| Methylphenidate | 1 | 2006 | 58 | 0.260 |
Why?
|
| Amino Acid Sequence | 7 | 2010 | 2785 | 0.260 |
Why?
|
| Polyadenylation | 3 | 2016 | 57 | 0.260 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 33 | 0.260 |
Why?
|
| Trinucleotide Repeats | 3 | 2007 | 109 | 0.260 |
Why?
|
| Hyaluronan Receptors | 3 | 2001 | 68 | 0.260 |
Why?
|
| Luminescent Proteins | 1 | 2006 | 166 | 0.250 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 99 | 0.250 |
Why?
|
| Prader-Willi Syndrome | 1 | 2007 | 69 | 0.250 |
Why?
|
| COS Cells | 4 | 2014 | 283 | 0.250 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 131 | 0.250 |
Why?
|
| Molecular Biology | 1 | 2005 | 80 | 0.240 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 270 | 0.240 |
Why?
|
| Morpholinos | 2 | 2016 | 10 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 611 | 0.230 |
Why?
|
| Organ Specificity | 3 | 2014 | 444 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 4 | 2015 | 429 | 0.230 |
Why?
|
| Cardiomegaly | 1 | 2005 | 136 | 0.230 |
Why?
|
| Organ Size | 2 | 2019 | 466 | 0.220 |
Why?
|
| Sequence Deletion | 4 | 2010 | 537 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 783 | 0.220 |
Why?
|
| Neoplasms | 5 | 2014 | 3025 | 0.220 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 236 | 0.210 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 139 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2013 | 1134 | 0.200 |
Why?
|
| Heart Failure | 1 | 2016 | 2416 | 0.200 |
Why?
|
| Models, Biological | 3 | 2016 | 1533 | 0.200 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2015 | 37 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 230 | 0.200 |
Why?
|
| Down-Regulation | 4 | 2015 | 717 | 0.200 |
Why?
|
| Microtubules | 1 | 2023 | 131 | 0.190 |
Why?
|
| Transcriptome | 3 | 2018 | 1126 | 0.190 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 498 | 0.180 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 2 | 2010 | 16 | 0.170 |
Why?
|
| Male | 13 | 2018 | 65815 | 0.170 |
Why?
|
| Nucleotide Deaminases | 1 | 2000 | 2 | 0.170 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 1 | 2000 | 5 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2001 | 2703 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2005 | 869 | 0.170 |
Why?
|
| Chick Embryo | 4 | 2004 | 131 | 0.170 |
Why?
|
| Cell Nucleolus | 1 | 2020 | 50 | 0.170 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 88 | 0.170 |
Why?
|
| Insulin Resistance | 2 | 2004 | 684 | 0.170 |
Why?
|
| Brain | 6 | 2016 | 3217 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 4800 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 395 | 0.160 |
Why?
|
| CD58 Antigens | 1 | 2019 | 7 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 260 | 0.150 |
Why?
|
| Female | 14 | 2018 | 71586 | 0.150 |
Why?
|
| Conserved Sequence | 2 | 2014 | 298 | 0.150 |
Why?
|
| Alu Elements | 1 | 2019 | 66 | 0.150 |
Why?
|
| Homeostasis | 1 | 2023 | 748 | 0.150 |
Why?
|
| Cloning, Molecular | 5 | 2007 | 913 | 0.150 |
Why?
|
| Protein Binding | 6 | 2004 | 1836 | 0.150 |
Why?
|
| Genetic Variation | 3 | 2019 | 1621 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2011 | 791 | 0.140 |
Why?
|
| Quail | 2 | 2010 | 6 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 1874 | 0.140 |
Why?
|
| Genome, Human | 1 | 2005 | 1350 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2018 | 98 | 0.140 |
Why?
|
| Splicing Factor U2AF | 2 | 2015 | 12 | 0.140 |
Why?
|
| Horses | 1 | 2017 | 103 | 0.140 |
Why?
|
| Actins | 1 | 2019 | 352 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 319 | 0.140 |
Why?
|
| Bone Density | 1 | 2019 | 371 | 0.130 |
Why?
|
| Ion Transport | 1 | 2016 | 54 | 0.130 |
Why?
|
| Body Composition | 1 | 2019 | 563 | 0.130 |
Why?
|
| Half-Life | 1 | 2016 | 160 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 54 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 99 | 0.130 |
Why?
|
| Gene Targeting | 1 | 2017 | 185 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2019 | 499 | 0.130 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2016 | 19 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 212 | 0.130 |
Why?
|
| Circadian Clocks | 1 | 2016 | 66 | 0.120 |
Why?
|
| DNA, Complementary | 4 | 2011 | 472 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 263 | 0.120 |
Why?
|
| Genes, myc | 1 | 2015 | 107 | 0.120 |
Why?
|
| Protein Transport | 1 | 2016 | 387 | 0.120 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2016 | 126 | 0.120 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1995 | 13 | 0.120 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2015 | 59 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2018 | 809 | 0.120 |
Why?
|
| Proteins | 1 | 2020 | 1087 | 0.120 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 2 | 2007 | 11 | 0.120 |
Why?
|
| Genetic Vectors | 2 | 2011 | 970 | 0.120 |
Why?
|
| Plasmids | 3 | 2006 | 527 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 421 | 0.120 |
Why?
|
| Tremor | 1 | 2016 | 134 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 478 | 0.110 |
Why?
|
| Aging | 2 | 2016 | 1304 | 0.110 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2016 | 241 | 0.110 |
Why?
|
| Genomics | 1 | 2002 | 1676 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2016 | 627 | 0.110 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2013 | 3 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 243 | 0.110 |
Why?
|
| Calorimetry, Indirect | 1 | 2013 | 61 | 0.110 |
Why?
|
| Nucleic Acid Conformation | 2 | 2015 | 198 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 1995 | 497 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2018 | 1006 | 0.100 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 129 | 0.100 |
Why?
|
| Tissue Distribution | 3 | 2004 | 400 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 844 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2015 | 181 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2013 | 167 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 714 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 316 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2012 | 9 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 1439 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 1631 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 286 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2014 | 813 | 0.090 |
Why?
|
| tau Proteins | 2 | 2007 | 241 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 676 | 0.090 |
Why?
|
| Cardiotoxins | 1 | 2011 | 6 | 0.090 |
Why?
|
| Elapid Venoms | 1 | 2011 | 10 | 0.090 |
Why?
|
| Mice, Inbred mdx | 1 | 2011 | 46 | 0.090 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2011 | 27 | 0.090 |
Why?
|
| Lentivirus | 1 | 2011 | 86 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 676 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 321 | 0.090 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 56 | 0.090 |
Why?
|
| Gene Amplification | 2 | 2005 | 247 | 0.090 |
Why?
|
| Genetic Techniques | 1 | 2011 | 109 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2011 | 69 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 433 | 0.080 |
Why?
|
| Embryo Loss | 1 | 2010 | 26 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1911 | 0.080 |
Why?
|
| Cell Division | 1 | 2011 | 774 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 2122 | 0.080 |
Why?
|
| Mitochondria | 1 | 2015 | 743 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2002 | 4898 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2010 | 77 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2007 | 1702 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1760 | 0.080 |
Why?
|
| Base Pairing | 1 | 2009 | 42 | 0.080 |
Why?
|
| Ribonuclease III | 1 | 2010 | 103 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 761 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 90 | 0.080 |
Why?
|
| Therapeutics | 1 | 2009 | 8 | 0.080 |
Why?
|
| Purines | 3 | 2001 | 119 | 0.080 |
Why?
|
| RNA Interference | 1 | 2011 | 544 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 147 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 514 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2014 | 3638 | 0.070 |
Why?
|
| Protein Kinase C beta | 1 | 2007 | 21 | 0.070 |
Why?
|
| Serine-Arginine Splicing Factors | 2 | 2005 | 11 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2000 | 215 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2007 | 231 | 0.070 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 1998 | 65 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2007 | 644 | 0.060 |
Why?
|
| Mutagenesis | 3 | 1998 | 354 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 261 | 0.060 |
Why?
|
| Pregnancy | 1 | 2018 | 7515 | 0.060 |
Why?
|
| Body Weight | 1 | 2010 | 1034 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 332 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 338 | 0.060 |
Why?
|
| Tongue | 1 | 2005 | 35 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2005 | 20 | 0.060 |
Why?
|
| Point Mutation | 2 | 1997 | 360 | 0.060 |
Why?
|
| Penetrance | 1 | 2005 | 111 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 136 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2015 | 456 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2005 | 47 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2010 | 999 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 2764 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 78 | 0.060 |
Why?
|
| Genes | 1 | 2005 | 450 | 0.060 |
Why?
|
| Rats | 2 | 2004 | 3879 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1996 | 295 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 607 | 0.060 |
Why?
|
| Skin | 1 | 2007 | 551 | 0.060 |
Why?
|
| Adult | 5 | 2014 | 31925 | 0.060 |
Why?
|
| Spleen | 1 | 2005 | 291 | 0.060 |
Why?
|
| Cosmids | 1 | 2004 | 48 | 0.060 |
Why?
|
| Genomic Instability | 1 | 2006 | 244 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2006 | 836 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 746 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2004 | 220 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2018 | 1066 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 849 | 0.050 |
Why?
|
| Denys-Drash Syndrome | 1 | 2003 | 5 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2004 | 163 | 0.050 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2003 | 45 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2157 | 0.050 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 78 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2004 | 789 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2006 | 1667 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 49 | 0.050 |
Why?
|
| Sequence Analysis | 2 | 1999 | 54 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2003 | 77 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2003 | 95 | 0.050 |
Why?
|
| DNA | 2 | 1998 | 1675 | 0.050 |
Why?
|
| Testis | 1 | 2004 | 426 | 0.050 |
Why?
|
| Drosophila | 2 | 2015 | 824 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 2239 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 1384 | 0.040 |
Why?
|
| Forecasting | 1 | 2002 | 376 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 837 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 49 | 0.040 |
Why?
|
| Genes, Wilms Tumor | 1 | 2000 | 8 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 264 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 1006 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2000 | 38 | 0.040 |
Why?
|
| Deoxyribonucleases | 1 | 1999 | 27 | 0.040 |
Why?
|
| Clathrin Heavy Chains | 1 | 2018 | 1 | 0.040 |
Why?
|
| Clathrin Light Chains | 1 | 2018 | 3 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 50 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 258 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 35 | 0.040 |
Why?
|
| Dementia | 1 | 2003 | 485 | 0.030 |
Why?
|
| Computational Biology | 1 | 2002 | 887 | 0.030 |
Why?
|
| Middle Aged | 3 | 2014 | 29371 | 0.030 |
Why?
|
| Coturnix | 1 | 1996 | 5 | 0.030 |
Why?
|
| Myogenin | 1 | 1996 | 10 | 0.030 |
Why?
|
| Kidney | 1 | 2004 | 1410 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 560 | 0.030 |
Why?
|
| MyoD Protein | 1 | 1996 | 26 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2000 | 833 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2015 | 17 | 0.030 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2015 | 12 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 158 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1995 | 61 | 0.030 |
Why?
|
| Taq Polymerase | 1 | 1995 | 9 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2015 | 35 | 0.030 |
Why?
|
| Wood | 1 | 1995 | 11 | 0.030 |
Why?
|
| Electroretinography | 1 | 2015 | 123 | 0.030 |
Why?
|
| Rhodopsin | 1 | 2015 | 69 | 0.030 |
Why?
|
| Ataxins | 1 | 2015 | 114 | 0.030 |
Why?
|
| Plastics | 1 | 1995 | 15 | 0.030 |
Why?
|
| Cleavage Stimulation Factor | 1 | 2014 | 3 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 801 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1996 | 633 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1995 | 36 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 132 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 6584 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 127 | 0.030 |
Why?
|
| Ataxin-1 | 1 | 2015 | 162 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 295 | 0.030 |
Why?
|
| Vision, Ocular | 1 | 2015 | 139 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 217 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 612 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 777 | 0.030 |
Why?
|
| Globins | 1 | 1993 | 36 | 0.030 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1993 | 31 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 192 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2015 | 274 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 891 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1757 | 0.020 |
Why?
|
| RNA Caps | 1 | 1992 | 32 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 525 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 644 | 0.020 |
Why?
|
| Cytosol | 1 | 1992 | 168 | 0.020 |
Why?
|
| Luminescence | 1 | 2011 | 18 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2006 | 14776 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 13011 | 0.020 |
Why?
|
| Kinetics | 1 | 1992 | 1355 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 870 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 317 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3751 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2011 | 477 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1607 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2006 | 270 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 153 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 484 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 339 | 0.010 |
Why?
|
| RNA Probes | 1 | 2004 | 31 | 0.010 |
Why?
|
| Eye | 1 | 2006 | 246 | 0.010 |
Why?
|
| Fetus | 1 | 2007 | 599 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 3051 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1999 | 149 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 1999 | 168 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1124 | 0.010 |
Why?
|
| Purine Nucleotides | 1 | 1995 | 2 | 0.010 |
Why?
|
| Genomic Library | 1 | 1995 | 42 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 571 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 21717 | 0.000 |
Why?
|